(Date:11/21/2008)... one day lead to a novel technique to combat cance...ealthDay News) -- Belgian researchers have discove... of sugar for food, and this might lead to new tre...survive and proliferate, all cells in the body nee... [glucose], a process that requires oxygen. Compar...
(Date:11/21/2008)... Nov. 21 NursingCenter.com, the pr...n and peer reviewed content, has been,updated to ... registered,users. Powered by Lippincott Williams...des over 900 peer-reviewed continuing education ac...more than 50 leading nursing journals.,Lippincott...
(Date:11/21/2008).... 21 The general membership of the... three new individuals at their Annual,Awards Din...el in New York. A,Lifetime Achievement Award will...he Medical Advertising Hall of Fame are: , Rona... an account position,at Sudler & Hennessey. I...
(Date:11/21/2008)... popular drugs do not cause genetic damage that ca...ealthDay News) -- Two popular medications for trea...D) do not cause genetic damage linked to an increa..., The study, done by researchers at Duke Univer... Health, counters a previous one that reported bio...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
(Date:11/19/2008)... not achieve statistical significance , , I...armos Corporation (Nasdaq: PARS ) today announce...topical NanoEmulsion (NE) drug delivery technology... , The multi-center, randomized, double-blind...and efficacy of the Company,s 3% Diclofenac Dietha...
(Date:11/19/2008)...ov. 19 Biotech scientists increasi...ogy research to better understand the effects of n..., reports Genetic Engineering & Biotechnology...figuring out a new compound,s mechanism of action ...technique, according to the November 15 issue of ...
(Date:11/19/2008)...Payment from Roche- , , MONTVALE, N.J., Nov...als Corp. (Nasdaq: MEMY ) today announced that i... trial of R3487/MEM 3454, its lead alpha-7 nicotin...iated with schizophrenia (CIAS). The Company has ...gering a $5.0 million payment from its partner Roc...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 1Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 2Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 4Web Tool Aids Men in Prostate Decisions 12753 1Web Tool Aids Men in Prostate Decisions 12753 2Social Security Lifts 1 3 Million Children Out of Poverty 12751 1Social Security Lifts 1 3 Million Children Out of Poverty 12751 2Five Years of VA Health Care for Combat Veterans 12749 1Five Years of VA Health Care for Combat Veterans 12749 2... Be Presented at the American College of Cardiolog...-- AtheroGenics, Inc. (NASDAQ: AGIX) today,announc...lead drug,candidate, AGI-1067, did not show a diff...int; however, it did achieve a number of,other imp...ded a,reduction in the composite of "hard" atheros...
... 2007 - The antidepressant duloxetine, at,a once-d...ific pain,and emotional symptoms associated with d... study of 327 adult patients with at,least moderat...ented today at the 15th European Congress of Psych...er of a class of drugs commonly referred to as,ser...
Other Medicine Technology:AtheroGenics Reports ARISE Trial Results for AGI-1067 2AtheroGenics Reports ARISE Trial Results for AGI-1067 3AtheroGenics Reports ARISE Trial Results for AGI-1067 4In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 2In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 3In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 4In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 5In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 6Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: